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Abstract 12 
This study aimed to systematically review and appraise evidence on the short-term (e.g. 13 
morbidity, mortality) and long-term (obesity and non-communicable diseases, NCDs) health 14 
consequences of catch-up growth (versus no catch-up growth) in individuals with a history of 15 
low birth weight (LBW).We searched MEDLINE, EMBASE, Global Health, CINAHL plus, 16 
Cochrane Library, ProQuest Dissertations and Thesis, and reference lists. Study quality was 17 
assessed using the risk of bias assessment tool from the Agency for Health Care Research and 18 
Quality, and the evidence base was assessed using the GRADE tool. Eight studies in 7 19 
cohorts (2 from high-income countries, 5 from low-middle income countries) met the 20 
inclusion criteria for short-term (mean age: 13.4 months) and/or longer-term (mean age: 11.1 21 
years) health outcomes of catch-up growth which had occurred by 24 or 59 months. Of 5 22 
studies on short-term health outcomes, 3 found positive associations between weight catch-up 23 
growth and body mass and/or glucose metabolism; 1 suggested reduced risk of hospitalisation 24 
and mortality with catch-up growth. Three studies on longer-term health outcomes found 25 
catch-up growth was associated with higher body mass, BMI, or cholesterol. GRADE 26 
assessment suggested that evidence quantity and quality were low. Catch-up growth 27 
following LBW may have benefits for the individual with LBW in the short term, and may 28 
have adverse population health impacts in the long-term, but the evidence is limited. Future 29 
cohort studies could address the question of the consequences of catch-up growth following 30 
LBW more convincingly, with a view to informing future prevention of obesity and NCDs. 31 
 32 
Keywords: obesity; NCDs; infant feeding; catch-up growth; low birthweight. 33 
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Key Messages 34 
x Some evidence supports the view that early life catch-up growth (compared to no 35 
catch-up growth) following LBW is beneficial in the short-term, but harmful in the 36 
long-term 37 
x The evidence base is small (8 eligible studies), relatively low quality, and not entirely 38 
consistent 39 
x Making a strong case for the avoidance of catch-up growth as a target of NCD and 40 
obesity prevention strategy would not be evidence-based at present 41 
  42 
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INTRODUCTION 43 
Low birth weight (LBW), defined by the WHO as a birth weight <2500g (UNICEF, WHO 44 
2004), is common, particularly in low-middle income countries (LMICs). It is clear that LBW 45 
typically leads to poor health outcomes. Conservative estimates of LBW prevalence made by 46 
UNICEF and the WHO in 2004 suggested that at least 16% of births globally were LBW, 47 
with around 96% of these in LMICs (UNICEF, WHO 2004).  48 
$FFHOHUDWHG SRVWQDWDO µFDWFK-XS¶ JURZWK LQ OHQJWK ZHLJKW RU ERWh) is a common 49 
compensatory mechanism for LBW, which occurs typically in the first 24 months of postnatal 50 
life (Crowther et al 1998; Jaquet et al 2005). It is believed that catch-up growth is beneficial 51 
for the individual in the short-term (Victora et al 2001), but may create public health 52 
problems in the long-term because it may be associated with metabolic disturbances which 53 
increase the risk of some non-communicable diseases (NCDs) and obesity (Kramer et al 54 
2014; Jain et al 2012). It is believed that early catch-up growth, before around the age of two 55 
years, is beneficial for long-term health outcomes, but catch-up growth which occurs later 56 
than around 2 years increases risk of later obesity and NCDs (Victora et al 2008), but this 57 
evidence has not focused on individuals with LBW and has not been subject to systematic 58 
review and evidence appraisal. The extent to which catch-up growth might influence short-59 
term and long-term outcomes following LBW is therefore a major public health nutrition 60 
question, of particular importance for obesity and NCD prevention in LMICs.  61 
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Whether, and to what extent, catch-up growth following LBW in early life should be 62 
considered in future policy responses to the obesity and NCD crisis depends on the quantity, 63 
quality, and consistency of the evidence relating catch-up growth following LBW to short-64 
term and long-term health outcomes. No previous systematic review has considered 65 
differences in health outcomes following LBW in those with catch-up growth versus those 66 
without catch-up growth. One review (Nobili et al 2008), generated from a literature search in 67 
a single database, compared the effect of catch-up growth in LBW versus non LBW 68 
individuals, but did not compare outcomes for individuals born LBW with catch-up growth 69 
versus those without catch-up growth. A recent analysis of data from five birth cohorts in 70 
LMICs, not focused specifically on those born LBW, suggested that catch-up growth after 71 
two years of age would increase later risk of obesity and NCDs (Adair et al 2013). 72 
The primary aim of this study was therefore to examine the impact of catch-up growth 73 
(versus no catch-up growth) on health outcomes in those born LBW. A secondary aim was to 74 
critique the available evidence, identifying gaps and weaknesses, so that future studies might 75 
permit a more confident assessment of the impact of catch-up growth following LBW, as part 76 
of a more evidence-informed global approach to NCD and obesity prevention in the future. 77 
 78 
METHODS 79 
Eligibility criteria: studies; study participants; exposures and outcomes 80 
All study designs were eligible for inclusion in this review so long as they provided data for 81 
infants and children where catch-up growth occurred prior to 59 months, with a history of 82 
LBW as defined by the WHO (birth weight < 2500g)-only studies with participants who had 83 
a history of LBW as defined by WHO were included. Definitions of catch-up growth vary 84 
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between studies, and no international standard has been established. Study eligibility was 85 
therefore not limited by the definition of catch-up growth used, and studies were included so 86 
long as catch up growth was defined (including definitions based on Weight-for-age; Height-87 
for-age; Weight-for-height). 88 
The following outcomes were considered: direct measures of adiposity and proxies for 89 
adiposity; blood pressure; fasting blood glucose; impaired glucose tolerance; elevated 90 
glycosylated haemoglobin (HbA1c); insulin and insulin resistance; total blood cholesterol, 91 
triglycerides, lipoprotein levels (low density lipoprotein ± LDL, high density lipoprotein ± 92 
HDL), and cardio-metabolic risk scores which included any or all of the above indicators. 93 
Eligible measures of cardiovascular events were angina pectoris, stroke, myocardial infarct, 94 
and mortality. Risk of diabetes type 2 was also included. 95 
Search methods for identification of studies 96 
We searched the following electronic databases on 6 August 2014: MEDLINE (1946 to July 97 
week 4 2014); EMBASE (1974 to 2014 week 31); Global Health (1910 to 2014 week 30); 98 
CINAHL plus (1983 to August 2014); Cochrane Library (up to issue 7 of 12 July 2014); 99 
ProQuest Dissertations & Theses (1980 to August 2014). The journal Bulletin of the World 100 
Health Organisation was searched in Pubmed Central (1948 to 1st June 2014), and a hand 101 
search of the WHO South-East Asian Journal of Public Health and the publication lists of 102 
birth cohorts listed at http://www.birthcohorts.net/ was performed. In addition, we examined 103 
reference lists and citations of relevant studies. A search for new studies which had cited  104 
eligible studies was carried out in November 2015, but produced no additional eligible 105 
studies. Keywords were searched as subject headings indexed in databases and as free-text 106 
terms. Booleans were used to refine the search. The search strategy for Medline is given 107 
below (Figure 1). Controlled vocabulary and search syntax were modified as appropriate 108 
when searching other databases.  Only studies in the English language were included. 109 
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 110 
Data collection, management, and analysis 111 
Selection of studies 112 
AM and AC screened and cross-checked titles and abstracts independently to identify 113 
potentially relevant studies based on the above criteria. Full text reports of potentially 114 
relevant studies were assessed for eligibility independently by two reviewers (AM, JJR). 115 
Discrepancies were resolved by discussion and where needed, RMB arbitrated. A list of 116 
excluded studies was generated and reasons for exclusion recorded. 117 
Data extraction and management 118 
We used a standardised protocol for extracting relevant information from the studies. Data 119 
extraction was performed independently by two reviewers (AM and JJR) who resolved any 120 
differences by discussion.  121 
Quality assessment of included studies 122 
Quality of included studies was assessed independently by AM and JJR, cross-checked and 123 
discussed to resolve disagreement where required. We used the 10-item risk of bias 124 
assessment tool from the Agency for HealthCare Research and Quality (Viswanathan et al 125 
2013) to assess study quality formally. 126 
Assessment of publication bias 127 
,IWKHQXPEHURILQFOXGHGVWXGLHVDOORZHGVWXGLHVZHDLPHGWRDVVHVs reporting bias by 128 
using a funnel plot. 129 
Data synthesis and quality assessment of evidence 130 
Available data were not suitable for meta-analysis, with the exception of two studies which 131 
examined weight-for-age and height-for-age catch-up associations with fasting insulin (see 132 
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below). Weighted mean differences of insulin levels between children with and without 133 
catch-up growth were combined using random effect models to account for unobserved 134 
variables. Review manager 5.3 was used for data synthesis (RevMan 2014). Where studies 135 
were considered insufficiently similar to each other to be combined in a meta-analysis, results 136 
were described by timing of outcome (short-term-up to the age of 5 years; longer-term after 5 137 
years).  Estimates of effects were summarised in the GRADE Evidence Profile (Brozek 2008) 138 
along with the quality rating of the evidence. 139 
Where studies did not report the statistical significance of the group difference (between 140 
those with a history of LBW with catch-up growth vs. those with a history of LBW without 141 
catch-up growth), and where data were available, data were re-analysed to determine 142 
significance of a group difference using inverse variance and random effect models.  143 
 144 
RESULTS 145 
Search outcomes 146 
The searching and screening process is summarised in Figure 2. The literature search yielded 147 
881 records, of which 283 were duplicates. Titles and abstracts of 598 records were screened, 148 
resulting in 98 records for full-text screening (86 papers and 12 abstracts). Independent 149 
screening and cross-checking (AM, JJR) identified eight eligible studies for inclusion; 90 150 
records did not meet the inclusion criteria and thus were excluded. Reasons for exclusion are 151 
listed in Figure 2.   152 
Characteristics of included studies 153 
Included studies are summarised in Table 1a and 1b for short-term and longer-term outcomes, 154 
respectively. 155 
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General study characteristics. Of the eight studies (7 cohorts), five were prospective and 156 
three were cross-sectional. Evidence was available from two studies in high income countries 157 
and six (from five cohorts) from LMICs. 158 
Population. The total number of children studied was 535 (short-term health outcomes;Table 159 
1a) and 553 (longer-term health outcomes; Table 1b). LBW was defined by individual studies 160 
as: birth weight or length < 10th percentile of a sex and gestational age specific reference 161 
(Horta et al 2003; Han et al 2010; Rustogi et al 2013; Victora et al 2001); weight < 5th 162 
percentile for gestational age (Soto et al 2003; Rustogi et al 2013); weight and/or length < 163 
2SD below means for gestational age (Tenhola et al 2000); birthweight<2500g (Khandelwal 164 
et al 2014; Mai et al 2005). In all of the eligible studies participants met the WHO definition 165 
of LBW. Attrition rates of participants ranged from 16% to 86% with a median of 27%. Two 166 
studies did not report how many children were lost to follow-up (Han et al 2010; Rustogi et al 167 
2013). 168 
Exposure. Dichotomous definitions of catch-up growth FRPSDULQJ WKRVH ZKR µFDXJKW-XS¶169 
with those who did not) were used, but with different cut-offs to distinguish between those 170 
who caught up and those who did not: weight and/or height gain of    ]-scores 171 
(Khandelwal et al 2014; Rustogi et al 2013; Soto et al 2003; Victora et al 2001; Horta et al 172 
2003), or weight or height z-score increase from birth-follow-up of >2 (Tenhola et al 2000) or 173 
>0 (Han et al 2010). All included studies reported outcomes related to weight catch-up 174 
growth, while three also reported on height/length catch-up growth (Han et al 2010; Rustogi 175 
et al 2013; Soto et al 2013) and one provided additional data on weight-for-height catch-up 176 
growth (Rustogi et al 2013). Seven studies reported on catch-up growth up to the age of 24 177 
months and three studies included children who caught up after 24 months.  178 
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Comparison. All but three studies reported the impact of catch-up growth on markers of 179 
obesity or NCD risk compared to children who did not catch-up. Three studies provided data 180 
on the impact of change in weight z-scores between two time points on obesity, NCD risk, or 181 
risk or markers of NCDs (Horta et al 2003; Khandelwal et al 2014; Mai et al 2005).  182 
Outcomes. Of the nine eligible studies, 5 tested for associations between catch-up growth and 183 
early health outcomes (Han et al 2010; Khandelwal et al 2014; Rustogi et al 2013; Soto et al 184 
2003; Victora et al 2001; early outcomes defined here and pre-specified as aged < 5 years), 185 
while 4 tested for associations between catch-up growth and later health outcomes (Horta et 186 
al 2003; Mai et al 2005; Tenhola et al 2000; Victora et al 2001; later defined here and pre-187 
specified DVDJHG\HDUV; one of the eligible studies included both short-term and longer-188 
term outcomes (Victora et al 2001). The following NCD risk factors were assessed: BMI 189 
(Mai et al 2005; Soto et al 2003; percentage fat (Khandelwal et al 2014); glucose metabolism 190 
(Han et al 2010; Rustogi et al 2013; Soto et al 2013); blood pressure (Horta et al 2003); 191 
plasma cholesterol (Tenhola et al 2000); hospital admissions and mortality (Victora et al 192 
2001). 193 
Quality appraisal of included studies 194 
Overall, the quality across all included studies was low. Only two studies met five (i.e. low 195 
risk of bias) out of the 10 quality criteria; the remaining studies met less than five quality 196 
criteria. Attrition bias (applicable for cohort studies only) and selective reporting bias, were 197 
not addressed by included studies, and bias due to confounding was only rarely addressed.  198 
Selection bias. None of the included studies were at risk of selection bias. Children with or 199 
without catch-up growth were from the same cohort and thus quality item 2 was not 200 
applicable (differing recruitment strategy for individuals).  201 
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Detection bias. All studies failed to provide adequate details on whether the assessor was 202 
blinded to the exposure or outcome and thus the studies were jXGJHGWREHRIµXQFOHDU¶ULVNRI203 
bias. Six out of nine studies used valid and reliable measures of exposure and outcome and 204 
WKXVZHUHRIORZULVNRIELDV+RZHYHUWKUHHVWXGLHVZHUHMXGJHGDVµXQFOHDU¶DVLQVXIILFLHQW205 
information was reported (Horta et al 2003; Rustogi et al 2013; Victora et al 2001). 206 
Attrition bias. Attrition bias was not applicable in the longitudinal studies which used cross-207 
sectional analyses (Han et al 2010; Rustogi et al 2013; Soto et al 2003). The remaining 208 
prospective studies showed no differences in follow-up time between comparison groups. 209 
However, three of the prospective studies did not assess the impact of attrition which was 210 
high (>20%), with potential to bias the outcome (Horta et al 2003; Khandelwal et al 2014; 211 
Tenhola et al, 2000). Thus these studies were at high risk of attrition bias. A further two 212 
studies did not assess the impact of attrition; however, their attrition rates were low and so 213 
less likely to bias the results (Mai et al 2005; Victora et al 2001). Therefore, the risk of 214 
attrition bias was low. 215 
Selective reporting bias. The majority of studies did not refer to a published study protocol 216 
which would allow assessment of whether all predetermined outcome measures were 217 
reported. Thus for these studies thHULVNRIVHOHFWLRQELDVZDVMXGJHGWREHµXQFOHDU¶ (Han et al 218 
2010; Horta et al 2003; Mai et al 2005; Rustogi et al 2013; Victora et al  2001). For three 219 
studies it was possible to determine that relevant outcomes were not reported ( Khandelwal et 220 
al 2014; Soto et al 2003; Tenhola et al 2000) thus the risk of selective reporting was judged to 221 
be high. Assessment of missing adverse events or harms was not applicable to all included 222 
studies. 223 
Bias due to confounding. One study took known confounding factors into account when 224 
analysing the association between catch-up growth and non-communicable disease risk 225 
12 
 
factors and so was judged to be of low risk of confounding bias (Horta et al 2003). The 226 
remaining studies did not account for confounders and were therefore considered to be at 227 
high risk of bias. 228 
Synthesis of evidence 229 
Most studies showed a high level of heterogeneity in terms of study design, length of follow-230 
up, definition of the catch-up growth, timing of catch-up growth, and outcomes assessed. 231 
Therefore, a quantitative synthesis of the evidence in a meta-analysis was not suitable except 232 
for one outcome measure. The evidence is described largely narratively by timing of outcome 233 
assessment below. 234 
Short-term outcomes of catch-up growth in LBW children 235 
Of the studies that provided data on short-term outcomes, all referred to weight catch-up 236 
growth; only two studies (Rustogi et al 2013; Soto et al 2003) assessed the association of 237 
length/height catch-up growth on short-term health. Findings for weight and/or length catch-238 
up growth can be found in Table 1a (by study) and 2a (by outcome). Reported short-term 239 
outcomes were hospital admission, body mass and glucose metabolism up to the age of 30 240 
months, the mean age at outcome measurement was 13.4 months.  241 
One study suggested that catch-up growth was associated with reduced risk of hospitalisation: 242 
hospitalisation (all-cause) was significantly lower in children with catch-up growth (n=304) 243 
compared to children without (n=25; Victora et al 2001). Two studies found significantly 244 
higher fat mass by 5.7% (95%CI 0.0 to 11.4%; n=27; Khandelwal et al 2014) and BMI by 245 
1.30 kg/m2 (95%CI 1.20 to 1.40 kg/m2, n=85; Soto et al 2003) in children with catch-up 246 
growth compared to children without catch-up growth at 3 and 12 months, respectively. 247 
Three studies assessed the association between catch-up growth and glucose metabolism 248 
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(fasting glucose or insulin or insulin sensitivity; Han et al 2010; Rustogi et al 2013; Soto et al 249 
2003). One study found no association between catch-up growth and fasting glucose (Han et 250 
al 2010). Meta-analysis of the other two studies indicated higher fasting insulin levels of 2.54 251 
uIU/ml (95% CI 2.33 to 2.76 uIU/ml, p< 0.001, I2=0%) in children with weight catch-up 252 
growth (n=50) compared to the no weight catch-up growth group (n=54). Individual study 253 
findings on the association between height catch-up growth and fasting insulin were 254 
inconclusive. However, pooled mean differences showed higher fasting insulin levels of 2.00 255 
uIU/ml (95%CI 1.70 to 2.29 uIU/ml, p<0.001, I2=0%) in children with height/length catch-up 256 
growth. Insulin sensitivity was more impaired in children without weight and/or height catch-257 
up growth compared to children that showed weight and/or height catch-up growth at 3 258 
months (Rustogi et al 2013) and 12 months (Soto et al 2003, Table. 2a). 259 
Longer-term outcomes of catch-up growth in LBW children 260 
Longer-term outcomes were available for weight catch-up growth from all studies and for 261 
height catch-up growth by one study (Tenhola et al 2000). Reported longer-term outcomes 262 
between 5-15 years (mean age 10.2 years) were mortality, body mass index, blood pressure, 263 
and cholesterol levels. Findings are summarized for each study in Table 1b and by outcome 264 
in Table 2b. 265 
Based on one single study (Victora et al 2001), mortality by the age of 5 years was (non-266 
significantly) lower in children with catch-up growth compared to those with no catch-up 267 
growth.  BMI at age 12 years was significantly correlated with changes in weight z-scores 268 
between birth and 6 months and between birth and 18 months (n=74). The correlation 269 
coefficients were 0.34 and 0.24, respectively (Mai et al 2005). There was no evidence of a 270 
significant association between catch-up growth and diastolic blood pressure at 15 years in 271 
one study (n=101; Horta et al 2003). Children with height (not weight) catch-up growth 272 
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(n=21) had a 13.8 fold (95%CI 2.0 to 97.5) increased risk of high total cholesterol levels of > 273 
4.8 mM/L at 12 years compared to children without catch-up growth (n=35; Tenhola et al 274 
2000).  275 
Quality and consistency of evidence 276 
The GRADE evidence profiles for short- and long-term outcomes are summarised in Table 277 
2a and b, respectively. The quality of evidence was very low for the outcomes percent body 278 
fat, BMI, glucose levels, insulin levels, insulin sensitivity, systolic and diastolic blood 279 
pressure, risk of high cholesterol levels for height catch-up growth and low for hospital 280 
admissions and mortality. The reason for the grades of very low to low quality was because 281 
evidence was available from predominantly low quality observational studies only. Evidence 282 
inconsistency could not be adequately assessed because for almost all outcomes only one or 283 
two studies were eligible. 284 
 285 
DISCUSSION 286 
Main study findings and implications 287 
The present study found a relatively small body of evidence of low to very low quality 288 
according to AHRQ and GRADE methodology which addressed the question of the impact of 289 
catch-up growth (versus no catch-up growth) in LBW infants on short-term and longer-term 290 
health outcomes. No previous systematic review addressed this research question. For some 291 
of the studies the main research questions were not the same as the research questions 292 
addressed by the present review. In addition, for studies conceived, conducted, and/or 293 
reported prior to the recent widespread use of AHRQ and GRADE methodology, low study 294 
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quality was likely due in part to the age of the studies and lack of awareness of the 295 
methodology. 296 
Consistency of the evidence is hard to assess because, for almost all of the outcomes, only 297 
single studies were available. With limited quantity and quality of evidence, and uncertainty 298 
over the consistency of the evidence, it cannot be concluded that catch-up growth following 299 
LBW increases risk of adverse cardio-metabolic health in later life. Long-term outcome data, 300 
in adults, were missing. 301 
Limitations of the review  302 
Meta-analysis of the studies identified in the present review was limited to one outcome and 303 
only two studies because of substantial heterogeneity between studies and lack of data on the 304 
same outcome measure. Publication bias could not be assessed formally because the number 305 
of eligible studies was too small. It may be of note that included studies reported both 306 
significant and non-significant associations of catch-up growth versus no catch-up growth on 307 
health outcomes of relatively small participant number. Thus the presence of publication bias 308 
on the grounds of effect sizes and study impact is less likely. We had planned subgroup-309 
analyses, e.g. examining differences by age, exposure characteristics such as being LBW as a 310 
result of being born too small for gestational age or appropriate for gestational age, gender, 311 
setting, study design, and sensitivity analyses (synthesizing all of the available evidence and 312 
then only those studies deemed to have low risk of bias), but the small number of eligible 313 
studies, and their heterogeneity, precluded such analyses. This review focused solely on 314 
research published in English language, and thus potentially relevant studies published in 315 
other languages might have been missed. Translating records into English language was not 316 
feasible for this review.  317 
Limitations of the evidence base and implications for future research 318 
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The research question asked by the present review is an important one for global public 319 
health nutrition, regardless of whether or not it can be answered with any great confidence at 320 
present. In order to answer it with evidence of higher quality, future research should address 321 
the issues summarised in table 3. Namely, (i) many of the eligible studies made no reference 322 
to study power; (ii) many failed to take into account confounders, despite potentially 323 
important differences between those with catch-up growth versus no catch up growth (e.g. 324 
greater prevalence or severity of morbidity in the latter); (iii) many studies did not account 325 
for attrition; (iv) substantial heterogeneity in the definitions of catch-up make it difficult to 326 
understand what exposure actually matters (iv) there was substantial heterogeneity inherent in 327 
the exposure. The LBW definition included individuals of widely varying birth weight, 328 
timing of catch-up growth will have varied, and includes both those born too early and those 329 
born too small- an important distinction (Lapillone and Griffin 2013)  which was made by 330 
some studies (Table 1) but not all. 331 
A large number of ineligible studies compared catch-up growth of LBW children with growth 332 
of children born at or above 2500g (Figure 2). Studies which were excluded because they did 333 
not meet the comparison group criterion might have suitable data available to answer the 334 
research question asked by the present study. Some studies which did not meet our inclusion 335 
criteria for other reasons can also provide useful evidence. Kramer et al (2014) did not 336 
compare formally between those who showed catch-up growth versus those who did not, but 337 
noted that those who caught-up had slightly higher adiposity than those who did not. In one 338 
large study from the USA Hemachandra et al (2007) treated catch-up growth as a continuous 339 
exposure variable, with no comparison between those who showed catch-up growth versus 340 
those who did not (so was ineligible here), but reported that those with higher gains in weight 341 
z score in infancy and early childhood had significantly increased risk of high blood pressure 342 
at age 7 years. 343 
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 344 
There is a need for a clearer understanding of the nature and timing of the exposure of catch-345 
up, more evidence on the short-term and long-term impacts of catch-up growth versus no 346 
catch-up growth in LBW infants, and whether the consequences of catch-up vary between 347 
children with a history of LBW versus those without. Researchers with access to existing (or 348 
planned cohorts) might consider this research question in future in order to address the 349 
evidence gaps identified by this review. Specific questions, such as the importance of the 350 
precise timing or rate of catch-up growth, the relative importance of length versus weight 351 
catch-up growth , whether health outcomes of catch-up growth differ for those born too early 352 
versus those born too small, and the mechanisms which relate catch-up growth to later health 353 
outcomes, could not be answered. 354 
 355 
Conclusions 356 
In summary, the present study has found some evidence that catch-up growth in those born 357 
LBW is beneficial relative to no catch-up in the short-term. The longer-term population 358 
health impact of catch up growth (versus no catch up growth) in those born LBW is less 359 
clear. Major weaknesses and gaps in the evidence, combined with the importance of the issue 360 
of catch-up growth to global population health, demonstrate that  further studies, or 361 
secondary analyses of available data, are required urgently. 362 
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Figure Legends 442 
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Figure 1 444 
Search Strategy in Medline (ovid) 445 
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Figure 2  447 
Literature Search: Study Flow Diagram 448 
 449 
Table 1a: Characteristics and short-term health outcomes of included studies 450 
 451 
BW: birth weight, SGA: small-for-gestational age, mo: months, y: year, B: unstandardized ƌĞŐƌĞƐƐŝŽŶĐŽĞĨĨŝĐŝĞŶƚ ?ɴ ?ƐƚĂŶĚĂƌĚŝǌĞĚƌĞŐƌĞƐƐŝŽŶĐŽĞĨĨŝĐŝĞŶƚ ?KZ ?ŽĚĚƐƌĂƚŝŽ ?^ ?ƐƚĂŶĚĂƌĚĚĞǀŝĂƚŝŽŶ ?/ ?ŽŶĨŝĚĞŶĐĞ452 
interval453 
Fasting glucose 
(mmol/L)
n=12
Mean (SD): 4.18 
(0.58)
0.528
Insulin sensitivity 
(HOMA)
n=12 4.15 (2.96) 0.356
1.4 mo 7.2 mo n=33
ɴA? ? ? ? ? ?
 ? ?A?/A? ? ? ? ?ƚŽ
6.70
0.13
3 mo 7.2 mo n=33
ɴA? ? ? ? ? ? ? ?A?/
0.67 to 9.33
0.03
7.2mo 7.2 mo n=33
ɴA? ? ? ? ? ? ? ?A?/
1.43 to 9.43 
0.01
1.4 mo 7.2 mo n=14
Mean (SD) = 
12.8 (7.6) 
0.06
3 mo 7.2 mo n=14
Mean (SD)= 
12.8 (7.6)
Not reported
weight 12-18 mo
fasting insulin 
(uIU/ml)
12-18mo n=32
Mean (SD)= 3.0 
(2.5)
0.01 none
length 12-18 mo
fasting insulin 
(uIU/ml)
12-18mo n=25
Mean (SD) = 3.2 
(2.2)
0.2 none
weight / 
height
12-18 mo
Fasting insulin 
(uIU/ml)
12-18mo n=20
Mean (SD)= 2.8 
(1.9)
0.06 none
BMI (kg/m2) n=22
Mean (SD)= 
15.9 (0.2) 
<0.001
fasting insulin 
(pmol/L)
n=22
Mean (SD): 14.9 
(2.3) 
<0.001
Insulin sensitivity 
AUC (pmol/minxL)
n=22
Mean (SD)= 
2215.4(461.6) 
0.4
Insulin sensitivity 
(1
st
 phase insulin 
release, pmol/L) 
n=22
Mean (SD)= 
303.5 (91.2) 
0.82
BMI (kg/m
2
) n=41
Mean (SD)= 
16.8(0.2) 
1
fasting insulin 
(pmol/L) 
n=41
Mean (SD)= 
20.9 (2.1) 
<0.001
Insulin sensitivity 
AUC (pmol/minxL) 
n=41
Mean (SD)= 
1767.6(199) 
<0.001
Insulin sensitivity 
(1st phase insulin 
release - pmol/L)
n=41
Mean (SD)= 
223.4 (27.3)
<0.001
All-cause Hospital 
admissions 
n=25
Proportion of 
children 
16.00%
Not reported
Diarrhoea - 
hospital 
admissions 
n=25 0.00% Not reported
Lower respiratory 
Infections - 
hospital 
admissions
n=25 4.00% Not reported none
Catch-up group p-value of difference ConfoundersLow BW/SGA definition Mean BW
Term / 
preterm
Definition Type Timing 
Han 2010 Cross-sectional Peking, China
Third Hospital, 
Peking University
not singletons, gestational age 
<33wks, non SGA,  1-min Apgar 
score <7, 5 min Apgar score <10, 
intrauterine infections, congenital 
malformations, major neonatal 
problems, breastfed <3 months, 
mothers with diabetes, gestational 
diabetes, chronic hypertention
29%
Outcome measure Time point No catch-up group
Study ID
Study characteristics Participant characteristics Exposure- catch-up growth Outcome
Study design Study location Recruitment setting Exclusion criteria Attrition rates
3mo
n=32
Mean (SD): 
4.32 (0.64)
none
n=32 2.11 (1.06)
below <10th percentile of 
the sex specific 
distribution for 
gestational age using 
birth weight standards of 
Chinese
1996.59g 
(353.15)
gestational 
age of >33 
weeks (mean 
36.46 
SD2.38wk)
The change of 
weight Z-score 
during the 3 
months > 0 Z-score 
was defined as 
catch-up growth
weight 3 mo
50% BW <2500g
2175 ± 
180g, z-
ƐĐŽƌĞA? ? ? ? ?
± 0.49
term: 
gestational 
age between 
37 and 42 
weeks
Changes in weight z 
score between birth 
and the follow up 
visits 
Weight
difference in z-
score စ0.67 in 
weight for age 
 ?ȴt )
WAZ
Khandelwal 
2014
Prospective 
cohort study
India not reported
birth weight <1500 g, breast 
feeding not possible,requirement 
of intravenous fluids, antibiotics, 
oxygen or NICU stay for more than 
24 h at birth, major congenital 
malformations, stigmata of 
intrauterine infections, genetic 
syndromes or chromosomal 
anomalies and residence more 
than 40 km from the study site
n=13
Mean (SD)= 
18.5(7.5)
FM%
gender, current age and current 
length
n=6 
Mean (SD)= 
21.4 (7.5) 
n=18
Mean (SD)= 
7.3 (9.2)
n=25
Mean (SD)= 
5.9(8.3)
n=30
Mean (SD)= 
5.8 (7.6)
Rustogi 2013
Cross -sectional  
study
India not reported not reported not reported
Cross -sectional Chile
neonatal units of 
Hospital San Borja 
Arriara´n and 
Hospital So´tero del 
ZŦǲŽ
significant medical, neurological, 
or genetic conditions,  on unusual 
diets or were taking any 
medication that could interfere 
with growth or appetite
Not reported
 weight or length < 
10thpercentile
not reported term
gain in weight/ 
length SDS or both 
of >0.67
1y
n=63
Mean (SD)= 
17.2(0.2) 
none
n=63
Mean (SD)= 
32.6 (4.6) 
n=63
Mean (SD)= 
2302.6 
n=63
Mean (SD) = 
298.8 (46.4) 
Victora 2001
Prospective 
cohort study
Pelotas, Brazil households not reported 15%
1y
n=44
Mean (SD)= 
16.8(0.2)
n=44
Mean (SD)= 
34.6(6.5) 
n=44
Mean (SD)= 
2790.8 
(400.9) 
n=44
Mean (SD)= 
374.8 (76.4)
birth weight  <5th 
percentile for gestational 
age, using Chilean birth 
weight standards
 2.1 SDS ±  
0.1
term: 
Gestational 
age 37-41wks
weight/lengths 
gain, between zero 
and 1 yr, greater 
than 0.67 SDS
weight 1y
height 1y
Soto 2003
30 mo
n=304 5.60%
family income, materal 
schooling, age
n=304 0.00%
n=304 2.30%
BW <10th cenitle of 
weight for gestational age 
of the Will iams curve
not reported
not reported 
for SGA
weight change in z-
scores >=0.66 from 
birth to 20 months
weight 20 mo
22 
 
Table 1b: Characteristics and long-term health outcomes of included studies 454 
 455 
BW: birth weight, SGA: small-for-gestational age, mo: months, y: year, B: unstandardizĞĚƌĞŐƌĞƐƐŝŽŶĐŽĞĨĨŝĐŝĞŶƚ ?ɴ ?ƐƚĂŶĚĂƌĚŝǌĞĚƌĞŐƌĞƐƐŝŽŶĐŽĞĨĨŝĐŝĞŶƚ ?KZ ?ŽĚĚƐƌĂƚŝŽ ?^ ?ƐƚĂŶĚĂƌĚĚĞǀŝĂƚŝŽŶ ?456 
CI: Confidence interval 457 
 458 
 459 
 460 
 461 
 462 
 463 
 464 
20 mo
42 mo
20 mo
42 mo
6 mo 12 y n=74 <0.01 None
18mo 12y n=74 <0.05 none
Victora 2001
Prospective 
cohort study
Pelotas, Brazil households not reported 15%
BW <10th centile of 
weight for gestational age 
of the Will iams curve
not reported
not reported 
for SGA
weight change in z-
scores >=0.66 from 
birth to 20 months
weight 20 mo mortality 5y Total n=329 Not significant none
Study ID
Study characteristics Participant characteristics Exposure- catch-up growth Outcome
Study design Study location Recruitment setting Exclusion criteria Attrition rates Outcome measure Time point No catch-up group Catch-up group p-value of difference ConfoundersLow BW/SGA definition Mean BW
Term / 
preterm
Definition Type Timing 
Horta 2003
prospective 
cohort study
Pelotas, Brazil
5 maternity 
hospitals
not reported 86%
family income, duration of breast 
feeding, gender, maternal height, 
and maternal smoking during 
pregnancy
B=-0.32, 95% CI -4.98 to 4.34
< 10th centile for 
gestational age and sex, 
according to the reference 
developed by Will iams et 
al
not reported
not reported 
for SGA
Changes in weight z 
score between birth 
and the follow up 
visits
weight
Tenhola 2000
Prospective 
cohort study
Finland
Kuopio University 
Hospital
Metabolic Disease 25%
not reported
changes of SDS in 
weight between 
postmenstrual age 
of 40 wk and follow-
up time points (6 
months, 18 
months)
weightMai 2005
prospective 
cohort
Sweden hospitals not reported 16% VLBW <1500g not reported
none
birth weight and/or length 
and/or ponderal index <2 
SD score below the 
respective mean for the 
gestational age
median 2452g 
(2367, 2537)
term
weight or height 
increase >= 2 SD 
score between birth 
and 5y
weight 5y
height 5y
75% lower in catch-up group
OR 1.0
OR 1.0
0.3
0.009
high cholesterol 
levels (> 4.8 mM) 
high cholesterol 
levels (> 4.8 mM) 
total n=34
OR 0.3, 95% CI 
0.1 to 1.9 
total n=35
OR 13.8, 95% CI 
2.0 to 97.5
12y
12y
BMI (kg/m
2
)
15y
B= -0.49;  95% CI -4.80 to 3.82 
not reported
systolic blood 
pressure 
diastolic blood 
pressure
total n= 101
B= 1.86, 95%CI -2.91 to 6.64
B= -0.01; 95% CI - 4.21 to 4.20
ĐŽƌƌĞůĂƚŝŽŶ ?ʌA? ? ? ? ?
ĐŽƌƌĞůĂƚŝŽŶ ?ʌA? ? ? ? ?
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Table 2a: GRADE evidence profile for short-term outcomes of catch-up growth 465 
Quality assessment No of patients Effect 
Quality 
No of 
studies 
Design Risk of bias Inconsistency Indirectness Imprecision 
Other 
considerations 
Catch-up 
growth 
No catch-up 
growth 
Relative 
(95% 
CI) 
Absolute 
Percentage fat mass ʹ weight catch-up at 3 months (follow-up 5.8 months) 
1 observational study  serious1 no serious 
inconsistency 
no serious 
indirectness 
serious2 none 13 14 - MD 5.7% higher 222 
VERY LOW 
Body Mass Index - weight catch-up at 12 months 
1 observational study  serious3 no serious 
inconsistency 
no serious 
indirectness 
no serious 
imprecision 
none 63 22 - MD 1.30 kg/m2 higher (1.20 to 
1.40 higher) 
222 
VERY LOW 
Body Mass Index - height catch-up at 12 months 
1 observational study  serious1 no serious 
inconsistency 
no serious 
indirectness 
no serious 
imprecision 
none 44 41 - MD 0.00 kg/m2 higher (-0.09 to 
0.09) 
222 
VERY LOW 
Fasting glucose - weight catch-up at 3 months 
1 observational study serious4 no serious 
inconsistency 
no serious 
indirectness 
no serious 
imprecision 
none 32 12 - MD 0.14 mmol/L higher  222 
VERY LOW 
Insulin sensitivity levels - weight catch-up 3 months (HOMA) and 12 months (AUC) 
2 observational studies  serious1 no serious 
inconsistency 
no serious 
indirectness 
serious5 none 95 34 - HOMA: MD 2.04 higher 
AUC: MD 87.2 pmol/minL 
lower 
222 
VERY LOW 
24 
 
Fasting insulin levels - weight catch-up at 12 ʹ 18 months 
2 observational studies (cross-
sectional) 
serious3 no serious 
inconsistency 
no serious 
indirectness 
no serious 
imprecision 
none 50 54 - Not pooled: mean ranged from 
2.6 to 4.3 uIU/ml higher 
222 
VERY LOW 
Hospital admission - weight catch-up at 20 months (follow-up mean 10 months) 
1 observational study no serious risk 
of bias 
no serious 
inconsistency 
no serious 
indirectness 
no serious 
imprecision 
none 304 25 - 10.4 % lower  22 
LOW 
1 Studies did not account for attrition and confounding variables, there was evidence of selective outcome reporting.2 Wide confidence intervals indicate imprecision, The sample size was low.3 Study did not account 466 
for confounders and selective reporting of outcomes was evident.4 Study did not account for confounding variables.5 Low sample size in the comparison group is likely to add imprecision to the overall effect. 467 
 468 
 469 
 470 
 471 
 472 
 473 
 474 
 475 
 476 
 477 
 478 
 479 
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Table 2b: GRADE evidence profile for long-term outcomes of catch-up growth 480 
Quality assessment No of patients Effect 
Quality 
No of 
studies 
Design Risk of bias Inconsistency Indirectness Imprecision Other considerations 
Catch-up 
growth 
No catch-up 
growth 
Relative 
(95% CI) 
Absolute 
Body Mass Index - weight catch-up at 6 and 18 months (follow-up 10.5-11.5 years) 
1 observational 
study 
serious1 no serious 
inconsistency 
serious2 no serious 
imprecision 
none 74 
 
- Correlation 0.34 to 0.24 
higher 
222 
VERY LOW 
Systolic blood pressure - weight catch-up at 20 months (study 2) (follow-up mean 13.3 years) 
1 observational 
study 
serious3 no serious 
inconsistency 
serious2 serious5 none 101 - B=0.49 mmHG lower         
(-4.80 to 3.82) 
222 
VERY LOW 
Diastolic blood pressure - weight catch-up at 20 months (follow-up mean 13.3 years) 
1 observational 
study 
serious3 no serious 
inconsistency 
serious2 serious5 none 101 - B=0.01 mmHG  lower        
(-4.21 to 4.2) 
222 
VERY LOW 
Systolic blood pressure - weight catch-up at 42 months (study 2) 
1 observational 
study 
serious3 no serious 
inconsistency 
serious2 serious5 none  101 - B=1.86 mmHG higher        
(-2.91 to 6.64) 
222 
VERY LOW 
Diastolic blood pressure - weight catch-up at 42 months (follow-up mean 12.5 years) 
1 observational 
studies 
serious3 no serious 
inconsistency 
serious2 serious5 none 101 - 0.32 lower (4.98 lower to 
4.34 higher) 
222 
VERY LOW 
Cholesterol levels - weight catch-up at 59 months (follow-up mean 7 years) 
1 observational 
studies 
serious3 no serious 
inconsistency 
no serious 
indirectness 
no serious 
imprecision 
none 21/55  
(38.2%) 
34/55  
(61.8%) 
OR 0.3 (0.1 to 1.9) 291 fewer per 1000 (from 
479 more to 136 more) 
222 
VERY LOW 
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Cholesterol levels - height catch-up at 59 months (follow-up mean 7 years) 
1 observational 
studies 
serious3 no serious 
inconsistency 
no serious 
indirectness 
serious5 strong association6 
reduced effect for RR >> 1 
or RR << 1 
20/55  
(36.4%) 
35/55  
(63.6%) 
OR 13.8 (2 to 97.5) 324 more per 1000 (from 
141 more to 358 more) 
222 
VERY LOW 
Mortality ʹ weight catch-up at 59 months (follow-up mean 3.3  years) 
1 
observational 
studies 
no serious risk 
of bias 
no serious 
inconsistency 
no serious 
indirectness 
no serious 
imprecision 
none 304 25 
- 
75% lower (3 vs 13 less per 
1000) 
22 
LOW 
1 Study did not account for confounding variables. 2 Study assessed effect of change in weight z-score over time rather than effect of catch-up vs no catch-up.3 Studies did not account for confounding and attrition. 4 481 
Study assessed the effect of change in weight z-score rather than effect of weight catch-up vs no weight catch-up. 5 Wide confidence intervals indicate imprecision, the sample size was small. 6 Study reported a large 482 
effect size. 483 
 484 
 485 
 486 
 487 
 488 
 489 
 490 
 491 
 492 
 493 
 494 
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Table 3: Summary of research suggestions for population, exposure, comparison, outcomes and data analysis 495 
Population Exposure Comparison Outcomes  Data analysis 
More research on low birth 
weight infants needed 
More focus on subgroups 
within the low birth weight 
population (e.g. SGA and 
AGA) 
Increased sample size to 
increase statistical power 
Reporting of reasons of 
attrition (e.g. mortality, 
drop out, moving away) 
Standardised definitions  
of length catch-up growth 
and weight catch up 
growth;  
More emphasis on 
trajectories of catch up;  
More emphasis on growth 
and anthropometric  end 
points (e.g catch up 
growth to height or length 
within the healthy range 
vs. stunting) 
Need for more research 
specifically comparing 
those with low birth 
weight and catch up 
growth vs LBW with no 
catch up growth 
Need for more evidence on  
a range of outcomes, but 
particularly adult health 
outcomes 
 
Multivariate regression 
analysis taking potential 
confounding variables into 
account 
Consideration of attrition 
and missing outcome data 
in data analysis 
 496 
